Stockscreener 앱 받기
8.155
1.68%
0.135
시간 외 거래:
8.16
0.005
+0.06%
Evolus Inc 주식(EOLS)의 최신 뉴스
August 2026's Leading Growth Companies With Insider Confidence - Sahm
Midday Stock Roundup: Mobix Labs Shares Fall 21% at Midday - Orange County Business Journal
Renaissance Technologies LLC Lowers Stake in Evolus, Inc. $EOLS - MarketBeat
Evolus, Inc. (EOLS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS - MarketBeat
Evolus Inc (EOLS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Evolus (NASDAQ:EOLS) Reaches New 1-Year HighHere's What Happened - MarketBeat
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade - Yahoo Finance
Evolus: The Injectable Platform Is Becoming The Real Moat (NASDAQ:EOLS) - Seeking Alpha
Evolus Inc (EOLS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Trading Systems Reacting to (EOLS) Volatility - Stock Traders Daily
Evolus (NASDAQ:EOLS) Rating Increased to Buy at Wall Street Zen - MarketBeat
Needham Maintains Evolus(EOLS.US) With Hold Rating - moomoo.com
BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Evolus Inc (EOLS) Stock News Today - TradingKey
Evolus, Inc. (EOLS) Investor Outlook: Analyzing 97.93% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews
Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Su - GuruFocus
Evolus, Inc. Q2 2026 Financial Results: Revenue, Risks, and Key Business Updates - Minichart
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ... - Yahoo Finance
Earnings call transcript: Evolus tops revenue forecast in Q2 2026, shares rise - Investing.com South Africa
Evolus Q2 Earnings Call Highlights - MarketBeat
Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2 - Yahoo Finance
Is Evolus Inc (EOLS) Undervalued After Q2 Earnings Beat? EPS: -0 - GuruFocus
Evolus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Evolus Q2 2026 slides: profitability streak continues, guidance raised - Investing.com
Evolus, Inc. Q2 2026: Revenue $84.08M, EPS ($0.12) — 10-Q Summary - TradingView
Evolus (EOLS) Releases Q2 2026 Earnings: Revenue Growth and Narrower Losses - Quiver Quantitative
Evolus (Nasdaq: EOLS) posts higher sales and manages sizable debt load - stocktitan.net
Evolus Q2 revenue rises 21%, lifts 2026 outlook - TradingView
Evolus Q2 2026 Earnings: Revenue Rises 21% as Adjusted EBITDA Stays Positive - TradingKey
Evolus (NASDAQ: EOLS) lifts 2026 guidance after Q2 revenue hits $84.1 million - Stock Titan
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook - marketscreener.com
Evolus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Evolus (NASDAQ:EOLS) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
Evolus Deadline Alert - TMX Newsfile
Evolus Expands Symatese Partnership into Three New Markets - Orange County Business Journal
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme in Canada, Australia, and New Zealand - marketscreener.com
Evolus expands hyaluronic acid gel rights to three markets By Investing.com - Investing.com Nigeria
Evolus expands hyaluronic acid gel rights to three markets - Investing.com
Evolus, Inc. (NASDAQ: EOLS) extends Estyme deal to $500M markets - Stock Titan
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand - Yahoo Finance
Evolus Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Perceptive Advisors LLC Acquires New Stake in Evolus, Inc. $EOLS - MarketBeat
Evolus, Inc. (NASDAQ:EOLS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Evolus (EOLS) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Evolus Inc (EOLS) Balance Sheet - TradingKey
Evolus Inc (EOLS) Income Statement - TradingKey
Evolus Inc (EOLS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
EOLS|Evolus Inc|Price:5.980|Chg%:-0.010 - TradingKey
Evolus Inc (EOLS) Institutional Confidence - TradingKey
Evolus Inc (EOLS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Evolus, Inc. Common Stock Revenue Breakdown – NASDAQ:EOLS - TradingView
Evolus Inc (EOLS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Evolus, Inc. (EOLS) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Evolus Inc (EOLS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Evolus, Inc. (EOLS) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Evolus Inc (EOLS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Evolus, Inc. (EOLS) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Press Release: Evolus to Report Second Quarter Financial Results on August 5, 2026 - Moomoo
Evolus to Report Second Quarter Financial Results on August 5, 2026 - Yahoo Finance
Evolus Inc. (EOLS) Slips 3.2% as Stock Approaches Key Support LevelCall Wall - dars.gov.et
0.79%
5.15%
자본화:
|
볼륨(24시간):